<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891393</url>
  </required_header>
  <id_info>
    <org_study_id>26014</org_study_id>
    <nct_id>NCT04891393</nct_id>
  </id_info>
  <brief_title>The Effects of Caffeine on Human Spinal Motoneurons</brief_title>
  <official_title>The Effects of Caffeine on Human Spinal Motoneurons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of orally ingested, commercially available, coffee (3 mg/kg&#xD;
      of caffeine) on the excitability of human spinal motoneurons of the lower leg.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, it has been shown that human spinal motoneurons do not simply act as a binary&#xD;
      control system. Instead, they are regulated by intrinsic properties that can elicit lingering&#xD;
      effects on the descending motoneuron. Caffeine, one of the world's most popular&#xD;
      over-the-counter supplements, can potentially augment these characteristics of motoneurons.&#xD;
      Using decomposition software and non-invasive, high-density surface electromyography, it is&#xD;
      possible to extract the characteristics of these motoneurons. This project will utilize a&#xD;
      double-blind, inactive-placebo controlled, crossover design study to examine and quantify the&#xD;
      effects of caffeine on motoneuron excitability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motoneuron excitability (Delta-f)</measure>
    <time_frame>Measured repeatedly at set intervals; Pre-Intervention &amp; 30, 60, 90 minutes post-Intervention</time_frame>
    <description>Changes in motorneuron excitability, as quantified by Delta-F values. A paired motor unit technique will be utilized (Gorassini et al., 2002). (Typically, these values range from -5 to +10).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor Unit Discharge Rate</measure>
    <time_frame>Measured repeatedly at set intervals; Pre-Intervention &amp; 30, 60, 90 minutes post-Intervention</time_frame>
    <description>Changes in motor unit discharge rate. This is a single value that ranges from, approximately, 0 to 30.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Coherence</measure>
    <time_frame>Measured repeatedly at set intervals; Pre-Intervention &amp; 30, 60, 90 minutes post-Intervention</time_frame>
    <description>Changes in coherence values. Coherence provides a normalized value of the strength of correlation in the frequency domain. The magnitude of the correlation of the Fourier transforms of two spike trains is squared producing a value between 0 and 1, with 1 corresponding to a perfect linear prediction at a particular frequency (Rosenberg et al., 1989). This will be calculated using the composite spike train (Negro &amp; Farina, 2012) and, finally, z-transformed to allow for between-trial comparisons.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Unit Recruitment Threshold</measure>
    <time_frame>Measured repeatedly at set intervals; Pre-Intervention &amp; 30, 60, 90 minutes post-Intervention</time_frame>
    <description>Changes in motor unit recruitment threshold. As assessed by determining the amount of force (percentage of maximum volitional force output) needed to recruit an individual motor unit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-dose, orally ingested, instant coffee.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single-dose, orally ingested, instant decaffeinated coffee (equal weight to intervention dose).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coffee</intervention_name>
    <description>Starbucks brand &quot;Via&quot; instant coffee. (Caffeine Content: 3 mg / kg)</description>
    <arm_group_label>Caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Decaffeinated coffee</intervention_name>
    <description>Starbucks brand &quot;Via&quot; instant decaffeinated coffee. (Caffeine Content: 15 - 25 mg)</description>
    <arm_group_label>Inactive Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        ‚óè Between 18 and 70 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant neurological or orthopedic injuries, which may limit volitional torque&#xD;
             generation in the tested muscles.&#xD;
&#xD;
          -  Significant change in the subjects' health or treatment in the past month.&#xD;
&#xD;
          -  Known history of cardiovascular pathology (to include: uncontrolled hypertension,&#xD;
             cardiac arrhythmias) or medical restrictions to caffeine ingestion.&#xD;
&#xD;
          -  Allergies or dislike of coffee.&#xD;
&#xD;
          -  Women who are pregnant will be excluded due to potential forces at trunk from pelvic&#xD;
             safety harness and due to potential adverse effects of caffeine on the developing&#xD;
             child.&#xD;
&#xD;
          -  Women who are breastfeeding will be excluded due potential adverse effects on the&#xD;
             breastfeeding infant from caffeine administration.&#xD;
&#xD;
          -  Adults unable to consent, minors, pregnant women, and prisoners will not be included.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Thompson, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher Taylor, RN, BSN</last_name>
    <phone>215-204-5247</phone>
    <email>taylor.chris@temple.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gorassini M, Yang JF, Siu M, Bennett DJ. Intrinsic activation of human motoneurons: possible contribution to motor unit excitation. J Neurophysiol. 2002 Apr;87(4):1850-8.</citation>
    <PMID>11929906</PMID>
  </reference>
  <reference>
    <citation>Rosenberg JR, Amjad AM, Breeze P, Brillinger DR, Halliday DM. The Fourier approach to the identification of functional coupling between neuronal spike trains. Prog Biophys Mol Biol. 1989;53(1):1-31. Review.</citation>
    <PMID>2682781</PMID>
  </reference>
  <reference>
    <citation>Farina D, Negro F. Accessing the neural drive to muscle and translation to neurorehabilitation technologies. IEEE Rev Biomed Eng. 2012;5:3-14. doi: 10.1109/RBME.2012.2183586. Review.</citation>
    <PMID>23231985</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 11, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Motor Neuron</keyword>
  <keyword>Excitability</keyword>
  <keyword>Caffeine</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

